
Nancy J. Leith
Examiner (ID: 17546, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1805, 1815, 1941, 1811 |
| Total Applications | 1477 |
| Issued Applications | 1013 |
| Pending Applications | 187 |
| Abandoned Applications | 292 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18144691
[patent_doc_number] => 20230018543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => CRISPR/CAS-MEDIATED GENE CONVERSION
[patent_app_type] => utility
[patent_app_number] => 17/672387
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672387
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672387 | CRISPR/CAS-MEDIATED GENE CONVERSION | Feb 14, 2022 | Abandoned |
Array
(
[id] => 17807771
[patent_doc_number] => 20220259606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHODS OF MODULATING NUCLEIC ACID STABILITY AND PROTEIN EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/590071
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590071
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590071 | METHODS OF MODULATING NUCLEIC ACID STABILITY AND PROTEIN EXPRESSION | Jan 31, 2022 | Abandoned |
Array
(
[id] => 17611888
[patent_doc_number] => 20220154167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS AND COMPOSITIONS FOR ASSESSING PROTEIN FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/589081
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589081
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/589081 | METHODS AND COMPOSITIONS FOR ASSESSING PROTEIN FUNCTION | Jan 30, 2022 | Pending |
Array
(
[id] => 19034515
[patent_doc_number] => 20240084330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
[patent_app_type] => utility
[patent_app_number] => 18/272158
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272158
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272158 | COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL | Jan 27, 2022 | Pending |
Array
(
[id] => 17946120
[patent_doc_number] => 20220333137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES
[patent_app_type] => utility
[patent_app_number] => 17/585694
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585694 | METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES | Jan 26, 2022 | Abandoned |
Array
(
[id] => 17595714
[patent_doc_number] => 20220145288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING FUNGAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 17/584950
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584950 | HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING FUNGAL STRAINS | Jan 25, 2022 | Abandoned |
Array
(
[id] => 17867430
[patent_doc_number] => 20220290166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => EXPRESSION CONSTRUCTS AND METHODS OF GENETICALLY ENGINEERING METHYLOTROPHIC YEAST
[patent_app_type] => utility
[patent_app_number] => 17/584028
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584028 | Expression constructs and methods of genetically engineering methylotrophic yeast | Jan 24, 2022 | Issued |
Array
(
[id] => 17889818
[patent_doc_number] => 11452765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Sequence specific antimicrobials
[patent_app_type] => utility
[patent_app_number] => 17/581614
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 10633
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581614 | Sequence specific antimicrobials | Jan 20, 2022 | Issued |
Array
(
[id] => 17595325
[patent_doc_number] => 20220144898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE NUCLEIC ACID-BASED AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/581467
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581467 | METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE NUCLEIC ACID-BASED AGENTS | Jan 20, 2022 | Pending |
Array
(
[id] => 17579146
[patent_doc_number] => 20220136001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => ARTIFICIAL NUCLEIC ACID MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/576583
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/576583 | ARTIFICIAL NUCLEIC ACID MOLECULES | Jan 13, 2022 | Pending |
Array
(
[id] => 19543378
[patent_doc_number] => 20240360414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => Systems and Methods for Base Editing Of HBG1/2 Gene Promoter and Fetal Hemoglobin Induction
[patent_app_type] => utility
[patent_app_number] => 18/272536
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272536 | Systems and Methods for Base Editing Of HBG1/2 Gene Promoter and Fetal Hemoglobin Induction | Jan 13, 2022 | Pending |
Array
(
[id] => 19624318
[patent_doc_number] => 12163125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Engineered class 2 type V CRISPR systems
[patent_app_type] => utility
[patent_app_number] => 17/572208
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 77
[patent_no_of_words] => 126604
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572208 | Engineered class 2 type V CRISPR systems | Jan 9, 2022 | Issued |
Array
(
[id] => 17533899
[patent_doc_number] => 20220112508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/555395
[patent_app_country] => US
[patent_app_date] => 2021-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555395
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555395 | INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS | Dec 17, 2021 | Abandoned |
Array
(
[id] => 18329526
[patent_doc_number] => 11634755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Crispr enzymes and systems
[patent_app_type] => utility
[patent_app_number] => 17/554333
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 345
[patent_figures_cnt] => 388
[patent_no_of_words] => 206996
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554333 | Crispr enzymes and systems | Dec 16, 2021 | Issued |
Array
(
[id] => 18666554
[patent_doc_number] => 11773432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => CRISPR enzymes and systems
[patent_app_type] => utility
[patent_app_number] => 17/554314
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 345
[patent_figures_cnt] => 388
[patent_no_of_words] => 206655
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554314 | CRISPR enzymes and systems | Dec 16, 2021 | Issued |
Array
(
[id] => 18590406
[patent_doc_number] => 11739290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Instruments, modules, and methods for improved detection of edited sequences in live cells
[patent_app_type] => utility
[patent_app_number] => 17/555336
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 78
[patent_no_of_words] => 56241
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555336 | Instruments, modules, and methods for improved detection of edited sequences in live cells | Dec 16, 2021 | Issued |
Array
(
[id] => 19381311
[patent_doc_number] => 20240271181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => METHODS FOR DETECTING HOMOGENOUS TARGETS IN A POPULATION WITH NEXT GENERATION SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 18/266692
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266692
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266692 | METHODS FOR DETECTING HOMOGENOUS TARGETS IN A POPULATION WITH NEXT GENERATION SEQUENCING | Dec 9, 2021 | Pending |
Array
(
[id] => 18085766
[patent_doc_number] => 11535887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Methods for spatial analysis using targeted RNA depletion
[patent_app_type] => utility
[patent_app_number] => 17/546625
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 38
[patent_no_of_words] => 36776
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546625 | Methods for spatial analysis using targeted RNA depletion | Dec 8, 2021 | Issued |
Array
(
[id] => 17482594
[patent_doc_number] => 20220090098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => GENETICALLY ENGINEERED VIBRIO SP. AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/541163
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541163 | GENETICALLY ENGINEERED VIBRIO SP. AND USES THEREOF | Dec 1, 2021 | Issued |
Array
(
[id] => 17474177
[patent_doc_number] => 20220081681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => ENGINEERED PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/533997
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 155522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533997 | Engineered proteins | Nov 22, 2021 | Issued |